Sonoma Orthopedic Products, Inc.

Canaccord Genuity is pleased to announce that on June 30, 2017, Sonoma Orthopedic Products, Inc., a medical device company focused on developing minimally-invasive fracture fixation and compression devices, and Arthrex, Inc., a global orthopedic device company, have entered into a definitive agreement under which Arthrex has agreed to purchase substantially all of Sonoma’s assets.

Canaccord Genuity served as financial advisor to Sonoma and its Board of Directors in connection with the transaction.

Sonoma is an orthopedic device company focused on the development of dramatically safer, minimally-invasive fracture fixation and compression devices. Sonoma offers clinically-proven intramedullary devices that provide precisely-controlled fixation from within the bone for the treatment of ankle, clavicle and wrist fractures.

Arthrex is a global medical device company and leader in new product development and medical education in orthopedics. Arthrex pioneered the field of arthroscopy and developed more than 11,000 innovative products and surgical procedures to advance minimally-invasive orthopedics worldwide.